NOW AVAILABLE: The 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

I am pleased to announce that Drug Channels Institute’s new 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers is now available for purchase and immediate download.

• Download a free 30-page report overview—including key industry trends, What's New in this edition, the Table of Contents, and a List of Exhibits

• Read the press release: HMP Global’s Drug Channels Institute Releases 2025 Economic Report on U.S. Pharmacies and PBMs, Examining $683 Billion Market

• Review pricing/license options and download the full 2025 report

Order before March 31, 2025 to receive special discounted pricing!

Now in its 16th edition, this report remains the most comprehensive, fact-based resource for understanding the entire U.S. drug pricing, reimbursement, and dispensing system. It serves as the ultimate guide to the complex web of interactions within U.S. prescription drug channels.

What's inside?

• 12 chapters, 540+ pages, and 268 exhibits

• Nearly 1,200 endnotes with hyperlinks to source materials

• Substantial new material—outlined on page ix of the report overview

There is simply no other resource that comes close in scope and depth to the 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers.

You can pay online using Visa, MasterCard, American Express, Discover, and PayPal. If you prefer to pay by corporate check or ACH, click here to request an invoice.

Want to bundle the report with DCI’s video webinars? Email Paula Fein (paula@drugchannels.net).

If you preordered, you should have received an email with download instructions last week. Didn’t get it? Contact us at dcisupport@hmpglobal.com, and we’ll take care of it.

WHAT’S GOING ON

Twice a year, the DCI team researches and writes two comprehensive, fact-based, and nonpartisan reports on drug channel economics. In some small way, we aim to make the world a slightly smarter place.

Our reports are widely used by nearly every company involved in the drug channel:

• Pharmaceutical manufacturers

• Wholesalers, pharmacists, pharmacy owners

• Hospitals, benefit managers, and managed care executives

• Policy analysts, investors, consultants, and more

So, this report helps you understand what your customers, partners, and competitors are reading.

The chart below illustrates the depth and breadth of the 2025 edition, with chapter numbers corresponding to each channel flow.

FUN FACTS ABOUT THE 2025 EDITION

• The 12 chapters are self-contained—you don't need to read them in order. (Really!)

• There are tons of internal hyperlinks to help you navigate and focus on what matters most to you.

• We’ve updated all market and industry data with the most current insights, including our annual analyses of the largest pharmacies, specialty pharmacies, and PBMs.

• Many sections have been expanded and reorganized to better reflect the latest industry developments. Check out the What’s New section in the report overview for details.

• You have the option to download an additional PowerPoint file with images of all 268 exhibits—making it easier to share insights with your team. (Note: All license versions include exhibits within the text.)

• There are a staggering 1,163 endnotes (!), most of which have direct hyperlinks to original source materials, giving you a deeper knowledge base beyond what’s in the report.

• Sadly, I had to remove all corny jokes and pop culture references. So, no memes and absolutely no references to SpongeBob SquarePants.

If you have any questions (before or after reading the report), just email me.

Enjoy!